| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |